Life Science Insights brings you the latest on drug development, clinical trials, regulatory science, biotechnology, and pharmacovigilance—highlighting innovative solutions that put patients first
Life Science Insights brings you the latest on drug development, clinical trials, regulatory science, biotechnology, and pharmacovigilance—highlighting innovative solutions that put patients first
For many queer individuals, the body holds not just memories of violence and trauma but also the potential for empowerment and healing. Beyond dysphoria,...
erex Ventures, a global investment and advisory firm, has announced a significant collaboration with Tokyo AI, a leading AI community in Japan. Together, they...
In the fast-evolving creator economy, many individuals and small brands find it challenging to turn their social media presence into tangible revenue. Kosmc.ai, a...
Swiggy, India’s leading food delivery platform, is preparing to seize new opportunities in the growing food delivery segment, despite the entry of competitors like...
In today’s age of media overload, finding credible, grounded, and trustworthy sources of information can be a challenge. Enter SMART Community Radio, a network...
As the automotive sector accelerates its transition to electric vehicles (EVs), a critical supply chain issue has emerged: the shortage of rare earth magnets....
Direct-to-consumer (D2C) beauty and personal care brand, Pilgrim, has successfully secured Rs 200 crore ($23 million) in a combination of primary and secondary funding. This investment round included participation from existing backers such as the Narotam Sekhsaria Family Office (NSFO), Vertex Ventures SEA, Sattva Family Office, and Mirabilis Investment Trust. Additionally, new investors like Vertex Growth Fund and Anicut Equity Continuum Fund joined the round.